Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4341)
All Articles published online
|
Jun 7, 2006 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Matsumoto H, Tamura S, Kamada Y, Kiso S, Fukushima J, Wada A, Maeda N, Kihara S, Funahashi T, Matsuzawa Y, Shimomura I, Hayashi N. Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J Gastroenterol 2006; 12(21): 3352-3358 [PMID: 16733851 DOI: 10.3748/wjg.v12.i21.3352] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i21/3352.htm |
| Number | Citing Articles |
| 1 |
Wen-Ze Xiao, Li Zhang. Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice. Chinese Medical Journal 2019; 132(20): 2438 doi: 10.1097/CM9.0000000000000488
|
| 2 |
Yu Wang, Karen S.L. Lam, Aimin Xu. Adiponectin as a therapeutic target for obesity‐related metabolic and cardiovascular disorders. Drug Development Research 2006; 67(8): 677 doi: 10.1002/ddr.20141
|
| 3 |
Amir J. Guri, Josep Bassaganya‐Riera. Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation. Obesity 2011; 19(4): 689 doi: 10.1038/oby.2010.230
|
| 4 |
Yoshihiro Kamada, Tetsuo Takehara, Norio Hayashi. Adipocytokines and liver disease. Journal of Gastroenterology 2008; 43(11): 811 doi: 10.1007/s00535-008-2213-6
|
| 5 |
Junkwon Cho, Rika Teshigawara, Masahiro Kameda, Shinpei Yamaguchi, Takashi Tada. Nucleus‐localized adiponectin is survival gatekeeper through miR‐214‐mediated AIFM2 regulation. Genes to Cells 2019; 24(2): 126 doi: 10.1111/gtc.12658
|
| 6 |
Mina Hamano, Yoshihiro Kamada, Shinichi Kiso, Kunimaro Furuta, Takashi Kizu, Norihiro Chatani, Mayumi Egawa, Takayo Takemura, Hisao Ezaki, Yuichi Yoshida, Kenji Watabe, Toshimitsu Hamasaki, Miyuki Umeda, Aiko Furubayashi, Kazuo Kinoshita, Osamu Kishida, Takashi Fujimoto, Akira Yamada, Yoshifumi Tsukamoto, Shusaku Tsutsui, Tetsuo Takehara, Norio Hayashi, Yuji Matsuzawa. Adiponectin negatively correlates with alcoholic and non‐alcoholic liver dysfunction: Health check‐up study of Japanese men. Hepatology Research 2013; 43(3): 238 doi: 10.1111/j.1872-034X.2012.01066.x
|
| 7 |
Hirokazu Takahashi, Kazuhiko Kotani, Kenichi Tanaka, Yuichiro Egucih, Keizo Anzai. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00588
|
| 8 |
Julie Jortay, Maximin Senou, Aurélie Delaigle, Laurence Noel, Tohru Funahashi, Norikazu Maeda, Marie C. Many, Sonia M. Brichard. Local Induction of Adiponectin Reduces Lipopolysaccharide-Triggered Skeletal Muscle Damage. Endocrinology 2010; 151(10): 4840 doi: 10.1210/en.2009-1462
|
| 9 |
DONG SHAN YU, FANG MEI AN, BANG DONG GONG, XIAO GANG XIANG, LAN YI LIN, HUI WANG, QING XIE. The regulatory role of microRNA-1187 in TNF-α-mediated hepatocyte apoptosis in acute liver failure. International Journal of Molecular Medicine 2012; 29(4): 663 doi: 10.3892/ijmm.2012.888
|
| 10 |
J. J. O. Turner, M. J. Smolinska, S. M. Sacre, B. M. J. Foxwell. Induction of TLR Tolerance in Human Macrophages by Adiponectin: Does LPS Play a Role?. Scandinavian Journal of Immunology 2009; 69(4): 329 doi: 10.1111/j.1365-3083.2008.02224.x
|
| 11 |
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
|
| 12 |
Annelise M. Poss, Scott A. Summers. Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00505
|
| 13 |
Makoto Nishida, Tohru Funahashi, Iichiro Shimomura. Pathophysiological significance of adiponectin. Medical Molecular Morphology 2007; 40(2): 55 doi: 10.1007/s00795-007-0366-7
|
| 14 |
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. Inflammation 2019; 42(3): 1056 doi: 10.1007/s10753-019-00967-6
|
| 15 |
Juichi Fukushima, Yoshihiro Kamada, Hitoshi Matsumoto, Yuichi Yoshida, Hisao Ezaki, Takayo Takemura, Yukiko Saji, Takumi Igura, Shusaku Tsutsui, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura, Shinji Tamura, Shinichi Kiso, Norio Hayashi. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatology Research 2009; 39(7): 724 doi: 10.1111/j.1872-034X.2009.00509.x
|
| 16 |
T.E. Silva, G. Colombo, L.L. Schiavon. Adiponectin: A multitasking player in the field of liver diseases. Diabetes & Metabolism 2014; 40(2): 95 doi: 10.1016/j.diabet.2013.11.004
|
| 17 |
Yoshitaka Uji, Hiroshi Yamamoto, Kazuhisa Maeda, Hiroshi Tsuchihashi, Hiroya Akabori, Tomoharu Shimizu, Yoshihiro Endo, Iichiro Shimomura, Tohru Tani. Adiponectin Deficiency Promotes the Production of Inflammatory Mediators While Severely Exacerbating Hepatic Injury in Mice with Polymicrobial Sepsis. Journal of Surgical Research 2010; 161(2): 301 doi: 10.1016/j.jss.2008.12.021
|
| 18 |
Katsuhisa Omagari, Chiaki Koba, Asuka Nagata, Linh Chi Thi Ngo, Mayu Yamasaki, Ayumi Fukuda, Masahiro Yuasa, Kazuhito Suruga, Nobutada Inada, Mayuko Ichimura-Shimizu, Koichi Tsuneyama. Olive leaf powder prevents nonalcoholic steatohepatitis in Sprague–Dawley rats fed a high-fat and high-cholesterol diet. Clinical Nutrition Open Science 2021; 37: 47 doi: 10.1016/j.nutos.2021.04.002
|
| 19 |
Carl Weidinger, Britta Siegmund. The Mesentery and Inflammation. Progress in Inflammation Research 2023; 90: 77 doi: 10.1007/978-3-031-17774-3_5
|
| 20 |
George Kolios, Vassilis Valatas, Elias Kouroumalis. Role of Kupffer cells in the pathogenesis of liver disease. World Journal of Gastroenterology 2006; 12(46): 7413-7420 doi: 10.3748/wjg.v12.i46.7413
|
| 21 |
Shinichi Mochizuki, Kazuo Sakurai. Dectin-1 targeting delivery of TNF-α antisense ODNs complexed with β-1,3-glucan protects mice from LPS-induced hepatitis. Journal of Controlled Release 2011; 151(2): 155 doi: 10.1016/j.jconrel.2011.01.026
|
| 22 |
Zhuying Guo, Shiting Wang, Qiang Jiao, Manghua Xu, Zhimei Xu. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats. Biomedicine & Pharmacotherapy 2009; 63(7): 537 doi: 10.1016/j.biopha.2008.08.012
|
| 23 |
Mingyan Zhou, Aimin Xu, Karen S.L. Lam, Paul K.H. Tam, Chi-Ming Che, Lawrence Chan, In-Kyu Lee, Donghai Wu, Yu Wang. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. Journal of Hepatology 2010; 53(6): 1108 doi: 10.1016/j.jhep.2010.05.034
|
| 24 |
Leon An, Xiaodong Wang, Arthur I. Cederbaum. Cytokines in alcoholic liver disease. Archives of Toxicology 2012; 86(9): 1337 doi: 10.1007/s00204-012-0814-6
|
| 25 |
Luisa Vonghia, Peter Michielsen, Sven Francque. Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2013; 14(10): 19867 doi: 10.3390/ijms141019867
|
| 26 |
Norihiro Chatani, Yoshihiro Kamada, Takashi Kizu, Satoshi Ogura, Kunimaro Furuta, Mayumi Egawa, Mina Hamano, Hisao Ezaki, Shinichi Kiso, Akihiko Shimono, Noriyuki Ouchi, Yuichi Yoshida, Tetsuo Takehara. Secreted frizzled‐related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver International 2015; 35(8): 2017 doi: 10.1111/liv.12757
|
| 27 |
Mizuho Hiramatsu-Ito, Rei Shibata, Koji Ohashi, Yusuke Uemura, Noriyoshi Kanemura, Takahiro Kambara, Takashi Enomoto, Daisuke Yuasa, Kazuhiro Matsuo, Masanori Ito, Satoko Hayakawa, Hayato Ogawa, Naoya Otaka, Shinji Kihara, Toyoaki Murohara, Noriyuki Ouchi. Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovascular Research 2016; 110(1): 107 doi: 10.1093/cvr/cvv282
|
| 28 |
Hisao Ezaki, Yuichi Yoshida, Yukiko Saji, Takayo Takemura, Juichi Fukushima, Hitoshi Matsumoto, Yoshihiro Kamada, Akira Wada, Takumi Igura, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura, Shinji Tamura, Shinichi Kiso, Norio Hayashi. Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice. Biochemical and Biophysical Research Communications 2009; 378(1): 68 doi: 10.1016/j.bbrc.2008.10.176
|
| 29 |
Ying Wang, Yumeng Wan, Guihong Ye, Pu Wang, Xiaowen Xue, Guanzhong Wu, Boping Ye. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice. European Journal of Pharmaceutical Sciences 2016; 93: 123 doi: 10.1016/j.ejps.2016.08.017
|
| 30 |
Li-Hua Lian, Xuejun Jin, Yan-Ling Wu, Xing Fu Cai, Jung Joon Lee, Ji-Xing Nan. Hepatoprotective Effects of Sedum sarmentosum on D-Galactosamine/Lipopolysaccharide–Induced Murine Fulminant Hepatic Failure. Journal of Pharmacological Sciences 2010; 114(2): 147 doi: 10.1254/jphs.10045FP
|
| 31 |
Mingyan Zhou, Aimin Xu, Paul K. H. Tam, Karen S. L. Lam, Bosheng Huang, Yan Liang, In-Kyu Lee, Donghai Wu, Yu Wang, Sookja Chung. Upregulation of UCP2 by Adiponectin: The Involvement of Mitochondrial Superoxide and hnRNP K. PLoS ONE 2012; 7(2): e32349 doi: 10.1371/journal.pone.0032349
|
| 32 |
Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Arturo Cesaro, Luca Rinaldi, Teresa Salvatore, Raffaele Marfella, Celestino Sardu, Elisabetta Moscarella, Felice Gragnano, Paolo Calabrò, Ferdinando Carlo Sasso. Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. Reviews in Cardiovascular Medicine 2021; 22(3) doi: 10.31083/j.rcm2203082
|
| 33 |
Mingyan Zhou, Aimin Xu, Paul K. H. Tam, Karen S. L. Lam, Lawrence Chan, Ruby L. C. Hoo, Jing Liu, Kim H. M. Chow, Yu Wang. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury†. Hepatology 2008; 48(4): 1087 doi: 10.1002/hep.22444
|
| 34 |
Jörn M. Schattenberg, Marcus Schuchmann. Diabetes and apoptosis: liver. Apoptosis 2009; 14(12): 1459 doi: 10.1007/s10495-009-0366-2
|
| 35 |
Tohru Funahashi, Yuji Matsuzawa. Adiponectin and the cardiometabolic syndrome: An epidemiological perspective. Best Practice & Research Clinical Endocrinology & Metabolism 2014; 28(1): 93 doi: 10.1016/j.beem.2013.09.002
|
| 36 |
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
|
| 37 |
Muhammad Jahangir Hossen, Md. Abdul Matin, Mahmudul Hasan Sikder, Md. Selim Ahmed, Moizur Rahman. Recent Advancements in Microbial Diversity. 2022; : 361 doi: 10.1016/B978-0-12-822368-0.00016-5
|
| 38 |
Hiroshi Yamamoto, Hajime Nakae, Yoshitaka Uji, Kazuhisa Maeda, Tohru Tani, Yutaka Eguchi. Plasma Adiponectin Levels in Acute Liver Failure Patients Treated with Plasma Filtration with Dialysis and Plasma Exchange. Therapeutic Apheresis and Dialysis 2015; 19(4): 349 doi: 10.1111/1744-9987.12344
|
| 39 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
|
| 40 |
Ling-Ling Jiang, Lin Li, Xiao-Fei Hong, You-Ming Li, Bing-Ling Zhang. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels. European Journal of Gastroenterology & Hepatology 2009; 21(6): 662 doi: 10.1097/MEG.0b013e328317f4b5
|
| 41 |
Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
|
| 42 |
Maria Pini, Joseph A. Sennello, Lawrence Chan, Giamila Fantuzzi. Adiponectin Deficiency Does Not Affect the Inflammatory Response to Endotoxin or Concanavalin A in Mice. Endocrinology 2006; 147(11): 5019 doi: 10.1210/en.2006-0855
|
| 43 |
Jason M. Konter, Jennifer L. Parker, Elizabeth Baez, Stephanie Z. Li, Barbara Ranscht, Martin Denzel, Frederic F. Little, Kazuto Nakamura, Noriyuki Ouchi, Alan Fine, Kenneth Walsh, Ross S. Summer. Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Suppression of Endothelial Cell Activation. The Journal of Immunology 2012; 188(2): 854 doi: 10.4049/jimmunol.1100426
|
| 44 |
Tomonori Aoyama, Kenichi Ikejima, Kazuyoshi Kon, Kyoko Okumura, Kumiko Arai, Sumio Watanabe. Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice #. Hepatology 2009; 49(5): 1636 doi: 10.1002/hep.22828
|
| 45 |
Raja Fayad, Maria Pini, Joseph A. Sennello, Robert J. Cabay, Lawrence Chan, Aimin Xu, Giamila Fantuzzi. Adiponectin Deficiency Protects Mice From Chemically Induced Colonic Inflammation. Gastroenterology 2007; 132(2): 601 doi: 10.1053/j.gastro.2006.11.026
|
| 46 |
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
|
| 47 |
Anel Hernández-Garces, José Agustín García Reynoso, Yasser Morera‐Gómez. Impact of radioactive emissions from the Laguna Verde nuclear power plant using CALPUFF. Annals of Nuclear Energy 2024; 205: 110603 doi: 10.1016/j.anucene.2024.110603
|
| 48 |
Shuji Terai, Toshihiko Matsumoto, Isao Sakaida. . Folia Pharmacologica Japonica 2007; 129(4): 271 doi: 10.1254/fpj.129.271
|
| 49 |
Pil-hoon Park, Megan R. McMullen, Honglian Huang, Varsha Thakur, Laura E. Nagy. Short-term Treatment of RAW264.7 Macrophages with Adiponectin Increases Tumor Necrosis Factor-α (TNF-α) Expression via ERK1/2 Activation and Egr-1 Expression. Journal of Biological Chemistry 2007; 282(30): 21695 doi: 10.1074/jbc.M701419200
|
| 50 |
Yu Wang, Mingyan Zhou, Karen S. L. Lam, Aimin Xu. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arquivos Brasileiros de Endocrinologia & Metabologia 2009; 53(2): 201 doi: 10.1590/S0004-27302009000200012
|
| 51 |
S. Esmaili, M. Hemmati, M. Karamian. Physiological role of adiponectin in different tissues: a review. Archives of Physiology and Biochemistry 2020; 126(1): 67 doi: 10.1080/13813455.2018.1493606
|
| 52 |
Mariana Mendes-Braz, Joilson O. Martins. Diabetes Mellitus and Liver Surgery: The Effect of Diabetes on Oxidative Stress and Inflammation. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/2456579
|
| 53 |
Hideharu Ogiyama, Yoshihiro Kamada, Shinichi Kiso, Hiroshi Araki, Takuya Yamada, Tamao Nishihara, Kenji Watabe, Yoshihiro Tochino, Shinji Kihara, Tohru Funahashi, Keishi Kanno, Iichiro Shimomura, Shusaku Tsutsui, Susumu Tazuma, Norio Hayashi. Lack of adiponectin promotes formation of cholesterol gallstones in mice. Biochemical and Biophysical Research Communications 2010; 399(3): 352 doi: 10.1016/j.bbrc.2010.07.075
|
| 54 |
Katsutoshi Tokushige, Etsuko Hashimoto, Haruka Noto, Satoru Yatsuji, Makiko Taniai, Nobuyuki Torii, Keiko Shiratori. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. Journal of Gastroenterology 2009; 44(9): 976 doi: 10.1007/s00535-009-0085-z
|
| 55 |
Luisa Vonghia, Sven Francque. Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyond. World Journal of Hepatology 2015; 7(15): 1905-1912 doi: 10.4254/wjh.v7.i15.1905
|
| 56 |
Yoshihiro Kamada, Tadashi Nakamura, Tohru Funahashi, Miwa Ryo, Hitoshi Nishizawa, Yukiyoshi Okauchi, Juichi Fukushima, Yuichi Yoshida, Shinichi Kiso, Iichiro Shimomura, Norio Hayashi. Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic Dysfunction. Journal of Clinical Gastroenterology 2009; 43(10): 995 doi: 10.1097/MCG.0b013e3181962de8
|
| 57 |
Motohiko Kato, Kenji Watabe, Toshimitsu Hamasaki, Miyuki Umeda, Aiko Furubayashi, Kazuo Kinoshita, Osamu Kishida, Takashi Fujimoto, Akira Yamada, Yoshifumi Tsukamoto, Shunsuke Yamamoto, Yoshihiro Kamada, Yuichi Yoshida, Shinichi Kiso, Shusaku Tsutsui, Shinji Kihara, Norio Hayashi, Yuji Matsuzawa. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. Journal of Gastroenterology 2011; 46(12): 1361 doi: 10.1007/s00535-011-0453-3
|
| 58 |
Jun Ren, Xihui Xu, Qiurong Wang, Sidney Y. Ren, Maolong Dong, Yingmei Zhang. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia. Journal of Molecular and Cellular Cardiology 2016; 93: 18 doi: 10.1016/j.yjmcc.2016.02.002
|
| 59 |
Takeshi Hijikawa, Masaki Kaibori, Yoichiro Uchida, Masanori Yamada, Kosuke Matsui, Takashi Ozaki, Yasuo Kamiyama, Mikio Nishizawa, Tadayoshi Okumura. INSULIN-LIKE GROWTH FACTOR 1 PREVENTS LIVER INJURY THROUGH THE INHIBITION OF TNF-α AND INOS INDUCTION IN D-GALACTOSAMINE AND LPS-TREATED RATS. Shock 2008; 29(6): 740 doi: 10.1097/SHK.0b013e31815d0780
|
| 60 |
Ding Liu, Shengyu Li, Zhihong Li. Adiponectin: A biomarker for chronic hepatitis C?. Cytokine 2017; 89: 27 doi: 10.1016/j.cyto.2015.10.016
|
| 61 |
Giamila Fantuzzi. Adiponectin in inflammatory and immune-mediated diseases. Cytokine 2013; 64(1): 1 doi: 10.1016/j.cyto.2013.06.317
|